• Latest Posts

Astellas gastric cancer drug meets phase 3 primary endpoint

Sosei Heptares and Lilly enter agreement on diabetes and metabolic diseases

Cell reprogramming can reverse fibrosis after heart attack

Japanese research offers hope for Fukuyama muscular dystrophy patients

Scientists identify genetic variant causing ALS in some patients

Arecor to start second type 2 diabetes clinical trial


Astellas meets primary endpoint in gastric cancer study

New mitochondria study could pave way for disease treatments

Novel branched lipid boosts mRNA delivery to cells

New radiopharmaceutical shrinks prostate cancer tumors

Study shows enhanced drug delivery to the brain

First to market doesn’t guarantee success